Clinical trial

A Trial Of Azithromycin SR For The Treatment Of Laryngopharyngitis or…

NCT00393835 · Pfizer, Industry · Completed

Key facts

NCT number NCT00393835
Title A Trial Of Azithromycin SR For The Treatment Of Laryngopharyngitis or Tonsillitis or Acute Bacterial Rhinosinusitis
Official title A Multicenter, Non-Randomized, Open Label Trial Of Azithromycin Sustained Release (SR) For The Treatment Of Laryngopharyngitis or Tonsillitis or Acute Bacterial Rhinosinusitis In Japan Adults
Lead sponsor Pfizer, Industry
Status Completed
Phase Phase 3
Study type Interventional
Conditions Upper Respiratory Tract Infection
Intervention type Drug
Interventions Azithromycin SR
Enrollment 99
Start date Nov 1, 2006
Primary completion May 1, 2007
Completion May 1, 2007
First posted Oct 30, 2006
Last update posted May 16, 2008
Countries Japan

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies